IP Library Assignment 055226/0671
Patent Assignment
Reel/Frame 055226/0671

Change of Name

Recorded: 2021-01-11 Pages: 5
Assignor
TARGACEPT, INC.
Executed: 2015-08-20
Assignee
CATALYST BIOSCIENCES, INC.
100 NORTH MAIN STREET, SUITE 1510, WINSTON-SALEM, NORTH CAROLINA, 27101
Covered Property (1)
Synthesis and Novel Salt Forms of (R)-5-((E)-2-Pyrrolidin-3-Ylvinyl)Pyrimidine
Application: 17/144,884 →
Publication: US 2021/0371401
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 11, 2021
From: AKIREDDY, SRINIVASA RAO; BHATTI, BALWINDER SINGH; CUTHBERTSON, TIMOTHY J.; DULL, GARY MAURICE
To: TARGACEPT, INC.
Reel/Frame 054960/0420 →
Assignment of Assignor's Interest Jan 11, 2021
From: CATALYST BIOSCIENCES, INC.
To: OYSTER POINT PHARMA, INC.
Reel/Frame 054960/0591 →
Patent Security Agreement Aug 5, 2021
From: OYSTER POINT PHARMA, INC.
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Reel/Frame 057104/0189 →
Release of Security Interest Feb 3, 2023
From: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
To: OYSTER POINT PHARMA INC.
Reel/Frame 062582/0873 →